Anthem this month added Intersect ENT‘s (NSDQ:XENT) Sinuva steroid-releasing implant to its updated formulary as a Tier 3 product, according to a note from Leerink analysts. The product is designated on Anthem’s formulary as “LD” – limited distribution – and is only available to certain pharmacies or wholesalers. Intersect ENT launched the product in the U.S. in April this year. Get the […]
Advanced Bionics wins FDA nod for MRI-safe HiRes Ultra 3D cochlear implant
Sonova Holding AG (SIX:SOON) subsidiary Advanced Bionics said yesterday that it won FDA approval for its HiRes Ultra 3D cochlear implant. The newly approved implant is cleared for use during magnetic resonance imaging examinations as it features a new magnet design which provides alignment with an external magnetic field in any direction. The magnet allows users […]
GN Hearing inks deal with Google, launches Beltone Amaze
GN Hearing (CPH:GN) this week announced it inked a partnership with Google (NSDQ:GOOG) to enable its hearing aid devices to directly stream audio from Android devices, and said it launched its Beltone Amaze hearing solution. With the Google deal, users will be able to connect and monitor their hearing aids on Android devices as well as […]
Frequency Therapeutics launches clinical trial for hearing loss drug
Frequency Therapeutics said today that the first patients have been treated in a Phase I/II clinical trial to assess its first-in-class drug candidate for hearing restoration. The 24-patient trial is slated to include people with stable sensorineural hearing loss. Participants will receive an injection of Frequency’s FX-322 or a placebo in one ear, with a follow-up visit […]
Intersect ENT shares tumble on Q2 results
Shares in Intersect ENT (NSDQ:XENT) fell today after the medical device maker missed sales expectations on Wall Street with its second-quarter financial results. The Menlo Park, Calif.-based company posted a net loss of -$4.2 million on sales of $26.3 million for the 3 months ended June 30, for sales growth of 9.7% compared with the same period […]
FDA grants de novo clearance to Med-El for Bonebridge hearing implant system
Cochlear implant maker Med-El USA said yesterday it won FDA de novo clearance for its Bonebridge bone conducting hearing implant system, with plans to launch the device this year. The newly cleared system is indicated for individuals 12 years and older with conductive hearing loss, mixed hearing loss or single-sided deafness, the Durham, N.C.-based company said. The […]
EndoGastric Solutions raises $25m
EndoGastric Solutions has raised $25.4 million in equity from 28 investors as part of a $35.5 million offering, according to a document filed with the SEC this week. The Washington-based company has not yet publicly stated what it plans to do with its newly-acquired funds. EndoGastric Solutions sells a device designed to reconstruct the gastroesophageal […]
Cochlear launches Nucleus app for Android devices
Cochlear Ltd. (ASX:COH) said today it launched a Google (NSDQ:GOOG) Android compatible version of its Nucleus smart application designed for use with its Nucleus 7 sound processor. With the update, users of the Nucleus 7 with Android devices can control their hearing through the linked application, and will gain access to a number of new features previously […]
Preceptis Medical closes Series B
Preceptis Medical said yesterday it closed a Series B round of financing to help support its Hummingbird tympanostomy tube system designed for pediatric ear tube placement procedures. The Plymouth, Minn.-based company’s Hummingbrid TTS tympanostomy tube system is designed to reduce pain for pediatric patients undergoing ear tube procedures, allowing moderate, conscious sedation with no need for […]
Neurent Medical sniffs out $11m for rhinitis device
Neurent Medical reportedly sniffed out a funding round of nearly $12 million for the minimally invasive rhinitis treatment it’s developing. The €9.3 million round for Oranmore, Ireland-based Neurent was led by Irish venture capital shop Fountain Healthcare Partners and included participation from Atlantic Bridge, Ireland’s Western Development Commission, Enterprise Ireland and a syndicate of U.S. and Irish medical […]
PavMed subsidiary Lucid Dx inks licensing deal with Case Western Univ.
Pavmed (NSDQ:PAVM) subsidiary Lucid Diagnostics said today it finalized a licensing agreement with Case Western Reserve University to commercialize its EsoCheck non-invasive cell sampling device and DNA biomarker test. The New York-based company said that the EsoCheck device has been shown to effectively and accurately detect Barrett’s Esophagus, which is a precursor to the most common […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 13
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube